FI53969C - Saosom utgaongsaemne vid framstaellning av terapeutiskt vaerdefulla 2 4-diamino-5-bensylpyrimidiner anvaendbar n-substituerad beta-amino-alfa-bensylakrylnitril vilken aer vaesentligen fri fraon foeroreningar foerorsakade av beta-amino-alfa-bensylidenpropionitril-isomeren och foerfarande foer dess framstaellning - Google Patents

Saosom utgaongsaemne vid framstaellning av terapeutiskt vaerdefulla 2 4-diamino-5-bensylpyrimidiner anvaendbar n-substituerad beta-amino-alfa-bensylakrylnitril vilken aer vaesentligen fri fraon foeroreningar foerorsakade av beta-amino-alfa-bensylidenpropionitril-isomeren och foerfarande foer dess framstaellning

Info

Publication number
FI53969C
FI53969C FI587/70A FI58770A FI53969C FI 53969 C FI53969 C FI 53969C FI 587/70 A FI587/70 A FI 587/70A FI 58770 A FI58770 A FI 58770A FI 53969 C FI53969 C FI 53969C
Authority
FI
Finland
Prior art keywords
beta
alpha
amino
framstaellning
væsentlig
Prior art date
Application number
FI587/70A
Other languages
English (en)
Other versions
FI53969B (fi
Inventor
Ronald Morton Cresswell
John William Mentha
Russell Seaman
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Priority to FI297673A priority Critical patent/FI55495C/fi
Priority to FI298073A priority patent/FI59403C/fi
Priority to FI297773A priority patent/FI55496C/fi
Priority to FI297973A priority patent/FI55180C/fi
Priority to FI297873A priority patent/FI55197C/fi
Priority to FI771479A priority patent/FI66594C/fi
Application granted granted Critical
Publication of FI53969B publication Critical patent/FI53969B/fi
Publication of FI53969C publication Critical patent/FI53969C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/60Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Steroid Compounds (AREA)
FI587/70A 1969-03-06 1970-03-04 Saosom utgaongsaemne vid framstaellning av terapeutiskt vaerdefulla 2 4-diamino-5-bensylpyrimidiner anvaendbar n-substituerad beta-amino-alfa-bensylakrylnitril vilken aer vaesentligen fri fraon foeroreningar foerorsakade av beta-amino-alfa-bensylidenpropionitril-isomeren och foerfarande foer dess framstaellning FI53969C (fi)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FI297673A FI55495C (fi) 1969-05-16 1973-09-25 Foerfarande foer framstaellning av alfa-bensylakrylonitrilderivat vilka aer vaesentligen fria fraon foeroreningar foerorsakade av beta-amino-alfa-bensylidenpropionitril-isomerer
FI298073A FI59403C (fi) 1969-03-06 1973-09-25 Foerfarande foer framstaellning av terapeutiskt anvaendbara 2,4-diamino-5-bensylpyrimidiner
FI297773A FI55496C (fi) 1969-03-06 1973-09-25 Foerfarande foer framstaellning av beta-anilino-alfa-bensylakrylonitrilderivat
FI297973A FI55180C (fi) 1969-03-06 1973-09-25 Foerfarande foer framstaellning av alfa-bensylakrylonitrilderivat
FI297873A FI55197C (fi) 1969-03-06 1973-09-25 Foerfarande foer framstaellning av beta-morfolino-alfa-3 4 5-trimetoxibensylakrylonitril
FI771479A FI66594C (fi) 1969-03-06 1977-05-10 Foerfarande foer framstaellning av beta-anilino-alfa-benzylakrylonitriler

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB1190969 1969-03-06
GB30247/69A GB1261455A (en) 1969-03-06 1969-03-06 Improvements in or relating to substituted acrylonitriles
GB2517169 1969-05-16
GB3024769 1969-06-13

Publications (2)

Publication Number Publication Date
FI53969B FI53969B (fi) 1978-05-31
FI53969C true FI53969C (fi) 1978-09-11

Family

ID=27448120

Family Applications (1)

Application Number Title Priority Date Filing Date
FI587/70A FI53969C (fi) 1969-03-06 1970-03-04 Saosom utgaongsaemne vid framstaellning av terapeutiskt vaerdefulla 2 4-diamino-5-bensylpyrimidiner anvaendbar n-substituerad beta-amino-alfa-bensylakrylnitril vilken aer vaesentligen fri fraon foeroreningar foerorsakade av beta-amino-alfa-bensylidenpropionitril-isomeren och foerfarande foer dess framstaellning

Country Status (18)

Country Link
US (1) US3697512A (fi)
JP (3) JPS519747B1 (fi)
BE (1) BE746846A (fi)
CH (3) CH580082A5 (fi)
CY (1) CY695A (fi)
DE (2) DE2010166C3 (fi)
DK (1) DK134317B (fi)
FI (1) FI53969C (fi)
FR (1) FR2036674A5 (fi)
GB (1) GB1261455A (fi)
HU (1) HU162316B (fi)
IE (1) IE34044B1 (fi)
IL (1) IL34006A (fi)
IT (1) IT1008514B (fi)
LU (1) LU60471A1 (fi)
NL (1) NL171579C (fi)
NO (1) NO136148C (fi)
SE (6) SE400555B (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3300939A (en) * 1963-10-17 1967-01-31 Dur O Wal National Inc Combination adjustable tie and joint reinforcement for wall constructions
US4052553A (en) * 1969-03-06 1977-10-04 Burroughs Wellcome Co. 5-benzyl pyrimidines intermediates therefore, and method
US3852276A (en) * 1969-03-06 1974-12-03 Burroughs Wellcome Co 5-benzyl pyrimidines intermediate therefore, and method
US3855265A (en) * 1969-03-06 1974-12-17 Burroughs Wellcome Co 5-benzyl pyrimidines intermediates therefore, and method
DE2051871A1 (en) * 1969-05-16 1971-11-18 The Wellcome Foundation Ltd., London Beta-amino-alpha-aryloxymethylacrylonitrile - and 2,4-diamino-5-benzylpyrimidine derivs. useful as antibacterial agents
BR6915082D0 (pt) 1969-05-16 1973-03-08 Wellcome Found Processo de preparacao de benzil-pirimidinas
GB1407971A (en) * 1971-04-16 1975-10-01 Wellcome Found 2,4-diamino -4-3,4,5-triethoxybenzyl pyrimidine and methods of preparation therefor
US4033962A (en) * 1975-06-26 1977-07-05 Hoffman-La Roche Inc. 2,4-Diamino-pyrimidine derivatives and processes
EP0001633A1 (en) * 1977-10-18 1979-05-02 The Wellcome Foundation Limited Processes for preparing tri-heterocyclic substituted methanes and their conversion into further intermediates useful in the preparation of pharmacologically active compounds
CH644111A5 (de) * 1981-05-15 1984-07-13 Siegfried Ag Verfahren zur herstellung eines substituierten pyrimidins.
FI65991C (fi) * 1981-05-28 1984-08-10 Farmos Oy Foerfarande foer framstaellning av terapeutiskt vaerdefull 5((3,4,5-trimetoxifenyl)metyl)-2,4-pyrimidindiamin
JPS5921346U (ja) * 1982-08-02 1984-02-09 清水建設株式会社 耐火被覆吹付け装置
DE3603577A1 (de) * 1986-02-06 1987-08-13 Joachim K Prof Dr Seydel Neue substituierte 2,4-diamino-5-benzylpyrimidine, deren herstellung und deren verwendung als arzneimittel mit antibakterieller wirksamkeit
WO2005095359A1 (en) * 2004-03-05 2005-10-13 F. Hoffmann-La Roche Ag Diaminopyrimidines as p2x3 and p2x2/3 antagonists
FR2929239B1 (fr) 2008-03-31 2010-04-16 Aker Yards Sa Navire pourvu de moyens de recuperation d'energie thermique et procede correspondant
CN101575303B (zh) * 2008-05-05 2012-07-18 华东理工大学 一种3-苯胺基-2-(3,4,5-三甲氧基苄基)丙烯腈的制备方法
CN101328138B (zh) * 2008-08-04 2013-09-18 寿光富康制药有限公司 甲氧苄啶的制备方法
AR090100A1 (es) * 2012-02-21 2014-10-22 Celgene Corp Procesos para la preparacion de la (s)-1-(3-etoxi-4-metoxifenil)-2-metanosulfoniletilamina
CN105294574B (zh) * 2015-11-25 2018-06-29 湖南湘易康制药有限公司 一种甲氧苄啶的合成方法
CN112480012A (zh) * 2020-12-30 2021-03-12 寿光富康制药有限公司 一种5-[(3,4,5-三甲氧基苯基)-甲基]-2,4-嘧啶二胺的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3049544A (en) * 1962-08-14 Method for the preparation of
DE1303727B (de) * 1959-09-03 1976-02-05 Ausscheidung aus: 14 45 176 The Wellcome Foundation Ltd., London Alpha-Arylidensubstituierte Propioni-Irile
NL122146C (fi) * 1960-09-02
US3485840A (en) * 1964-11-12 1969-12-23 Hoffmann La Roche 2,4-diamino - 5 - (2',4',5'-substituted benzyl) pyrimidines,intermediates and processes
DE1620729A1 (de) * 1965-07-08 1970-08-20 Wellcome Found Verfahren zur Herstellung von substituierten Benzylpyrimidinen
GB1142654A (en) * 1965-10-28 1969-02-12 Wellcome Found Cyano-acetals and their use in benzylpyrimidine synthesis

Also Published As

Publication number Publication date
SE409708B (sv) 1979-09-03
IE34044B1 (en) 1975-01-08
IL34006A (en) 1972-02-29
CH580082A5 (de) 1976-09-30
NO136148B (no) 1977-04-18
NL7003240A (fi) 1970-09-08
IE34044L (en) 1970-09-06
NO136148C (no) 1977-07-27
CH645884A5 (de) 1984-10-31
US3697512A (en) 1972-10-10
DE2010166C3 (de) 1987-01-22
DE2010166A1 (de) 1970-09-17
SE399427B (sv) 1978-02-13
CY695A (en) 1973-08-10
SE408551B (sv) 1979-06-18
DK134317C (fi) 1977-03-21
SE409031B (sv) 1979-07-23
JPS511716B1 (fi) 1976-01-20
SE7710288L (sv) 1977-09-14
NL171579C (nl) 1983-04-18
DE2010166B2 (de) 1978-04-27
BE746846A (fr) 1970-09-04
GB1261455A (en) 1972-01-26
HU162316B (fi) 1973-01-29
JPS519747B1 (fi) 1976-03-30
CH574399A5 (fi) 1976-04-15
FI53969B (fi) 1978-05-31
DK134317B (da) 1976-10-18
SE400555B (sv) 1978-04-03
LU60471A1 (fi) 1970-09-11
IT1008514B (it) 1976-11-30
DE2066039B2 (de) 1979-01-11
JPS5245704B1 (fi) 1977-11-17
FR2036674A5 (fi) 1970-12-24
SE409030B (sv) 1979-07-23

Similar Documents

Publication Publication Date Title
FI53969C (fi) Saosom utgaongsaemne vid framstaellning av terapeutiskt vaerdefulla 2 4-diamino-5-bensylpyrimidiner anvaendbar n-substituerad beta-amino-alfa-bensylakrylnitril vilken aer vaesentligen fri fraon foeroreningar foerorsakade av beta-amino-alfa-bensylidenpropionitril-isomeren och foerfarande foer dess framstaellning
FI56859B (fi) Foerfarande foer framstaellning av en elektrod foer anvaendning vid elektrolys
FI53923B (fi) Isotaktisk polypropylen-monofilamentsutur och foerfarande foer framstaellning av densamma
FI53673C (fi) Foerfarande foer framstaellning av kompoundstycken
FI53909C (fi) Foerfarande foer behandling av mjoelk och mejeribiprodukter
FI53810B (fi) Foerfarande foer avfaergning av avloppsvaetska fraon cellulosablekning
FI54287C (fi) Foerfarande foer rening av raoaceton
FI55861C (fi) Foerfarande foer konvertering av kolvaeten och katalytisk komposition foer utfoerande av foerfarandet
CH519943A (fr) Séparateur
FI55915C (fi) Anordning foer provning av relaeskydd och automatikutrustningar
FI53669C (fi) Skaerhuvud foer profilspaonskaerning av rundvirke
FI54140B (fi) Foerfarande foer katalytisk krackning av flera gasoljor
FI53941C (fi) Anordning foer resning av kartonger
FI54601C (fi) Foerfarande foer framstaellning av terapeutiskt verksamma 6-amidinopenicillansyraderivat
FI54038C (fi) Anordning foer beskiktning av en fiberslang
FI54494C (fi) Fraktionering av tallolja
FI54039C (fi) Foerfarande och anordning foer belaeggning av fiberslang
FI46520B (fi) Foerfarande foer attenuering av kalvdiarre-virus
FI55648B (fi) Analogifoerfarande foer framstaellning av foerening foer behandling av bronkospastiska tillstaond
FI54243B (fi) Apparat foer vaessning av slipskivor
FI53467C (fi) Foerfarande foer framstaellning av bundna fiberskivor
FI54107B (fi) Foerfarande foer framstaellning av butyrofenonderivat
FI54820C (fi) Foerfarande foer oxidering av sulfidsvavel till polysulfidsvavel och tillvaratagande av oxidationsmedlet vid alkalisk kokning av traemassa
BE758266R (fr) 2-thio-pyrimidine-nucleosides et leur
FI54002B (fi) Foerfarande foer framstaellning av bestruket papper